Showing results (51-60 of 138) with videos related to
Sort By:
Pageof 14
International Journal of Urology : Official Journal of the Japanese Urological Association|December 9, 2024
Prostate-specific antigen kinetics in Asian patients with metastatic castration-sensitive prostate cancer treated with apalutamide in the TITAN trial: A post hoc analysisDing-Wei Ye, Hirotsugu Uemura, Byung Ha Chung, et al.International Journal of Urology : Official Journal of the Japanese Urological Association|March 16, 2022
Safety and efficacy of apalutamide in Japanese patients with metastatic castration-sensitive prostate cancer receiving androgen deprivation therapy: Final report for the Japanese subpopulation analysis of the randomized, placebo-controlled, phase III TITAN studyHirotsugu Uemura, Gaku Arai, Hiroji Uemura, et al.Leukemia Research Reports|November 8, 2014
Deletion and deletion/insertion mutations in the juxtamembrane domain of the FLT3 gene in adult acute myeloid leukemiaKristin K Deeb, Matthew T Smonskey, HanChun DeFedericis, et al.Archives of Pathology & Laboratory Medicine|December 7, 2013
Correlations between cytogenetic and molecular monitoring among patients with newly diagnosed chronic myeloid leukemia in chronic phase: post hoc analyses of the Rationale and Insight for Gleevec High-Dose Therapy studyLuke P Akard, Jorge E Cortes, Maher Albitar, et al.Leukemia & Lymphoma|December 1, 2012
CD19 expression in acute leukemia is not restricted to the cytogenetically aberrant populationsJawad Francis, Avinash V Dharmadhikari, Sheila N J Sait, et al.Clinical Lymphoma, Myeloma & Leukemia|August 23, 2015
Decitabine and Sorafenib Therapy in FLT-3 ITD-Mutant Acute Myeloid LeukemiaMonica R Muppidi, Scott Portwood, Elizabeth A Griffiths, et al.Cancer Genetics and Cytogenetics|December 31, 2003
Massive hyperdiploidy and tetraploidy in acute myelocytic leukemia and myelodysplastic syndromeRenuka V Iyer, Sheila N J Sait, Sei-Ichi Matsui, et al.Leukemia Research|December 24, 2010
Hypoxia-inducible factor-1α protein expression is associated with poor survival in normal karyotype adult acute myeloid leukemiaGeorge Deeb, Mary M Vaughan, Ian McInnis, et al.Cancer Genetics and Cytogenetics|September 30, 2010
Genomic, immunophenotypic, and NPM1/FLT3 mutational studies on 17 patients with normal karyotype acute myeloid leukemia (AML) followed by aberrant karyotype AML at relapseEunice S Wang, Sheila N J Sait, David Gold, et al.British Journal of Haematology|November 4, 2004
Breast cancer resistance protein (BCRP/MXR/ABCG2) in adult acute lymphoblastic leukaemia: frequent expression and possible correlation with shorter disease-free survivalAttaya Suvannasankha, Hans Minderman, Kieran L O'Loughlin, et al.Pageof 14